These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 7703599

  • 21. Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease.
    Cominacini L, Garbin U, Pastorino AM, Davoli A, Campagnola M, De Santis A, Pasini C, Faccini GB, Trevisan MT, Bertozzo L.
    Atherosclerosis; 1993 Feb; 99(1):63-70. PubMed ID: 8461061
    [Abstract] [Full Text] [Related]

  • 22. Influence of natural antioxidants on in vitro lipoprotein oxidation.
    Dobreanu M, Módy E.
    Rom J Intern Med; 1997 Feb; 35(1-4):55-62. PubMed ID: 9562653
    [Abstract] [Full Text] [Related]

  • 23. Mechanisms involved in the in vitro modification of low density lipoprotein by human umbilical vein endothelial cells and copper ions.
    Cominacini L, Garbin U, De Santis A, Campagnola M, Davoli A, Pasini AF, Faccini G, Pasqualini E, Bertozzo L, Micciolo R, Pastorino AM, Lo Cascio V.
    J Lipid Mediat Cell Signal; 1996 Jan; 13(1):19-33. PubMed ID: 8821808
    [Abstract] [Full Text] [Related]

  • 24. Role of vitamin E in preventing the oxidation of low-density lipoprotein.
    Esterbauer H, Dieber-Rotheneder M, Striegl G, Waeg G.
    Am J Clin Nutr; 1991 Jan; 53(1 Suppl):314S-321S. PubMed ID: 1985404
    [Abstract] [Full Text] [Related]

  • 25. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia.
    Napoli C, Postiglione A, Triggiani M, Corso G, Palumbo G, Carbone V, Ruocco A, Ambrosio G, Montefusco S, Malorni A, Condorelli M, Chiariello M.
    Atherosclerosis; 1995 Dec; 118(2):259-73. PubMed ID: 8770320
    [Abstract] [Full Text] [Related]

  • 26. Formation of monohydroxy derivatives of arachidonic acid, linoleic acid, and oleic acid during oxidation of low density lipoprotein by copper ions and endothelial cells.
    Wang T, Yu WG, Powell WS.
    J Lipid Res; 1992 Apr; 33(4):525-37. PubMed ID: 1527476
    [Abstract] [Full Text] [Related]

  • 27. Effect of antioxidants on oxidative modification of LDL.
    Esterbauer H, Puhl H, Dieber-Rotheneder M, Waeg G, Rabl H.
    Ann Med; 1991 Apr; 23(5):573-81. PubMed ID: 1756027
    [Abstract] [Full Text] [Related]

  • 28. Increased lipid peroxidation in serum and low-density lipoproteins associated with aging in humans.
    Balkan J, Kanbağli O, Mehmetçik G, Mutlu-Türkoğlu U, Aykaç-Toker G, Uysal M.
    Int J Vitam Nutr Res; 2002 Oct; 72(5):315-20. PubMed ID: 12463107
    [Abstract] [Full Text] [Related]

  • 29. Dietary polyunsaturated fat intake is associated with low-density lipoprotein size, but not with susceptibility to oxidation in subjects with impaired glucose metabolism and type II diabetes: the Hoorn study.
    Bos G, Poortvliet MC, Scheffer PG, Dekker JM, Ocke MC, Nijpels G, Stehouwer CD, Bouter LM, Teerlink T, Heine RJ.
    Eur J Clin Nutr; 2007 Feb; 61(2):205-11. PubMed ID: 16943850
    [Abstract] [Full Text] [Related]

  • 30. LDL isolated from Greek subjects on a typical diet or from American subjects on an oleate-supplemented diet induces less monocyte chemotaxis and adhesion when exposed to oxidative stress.
    Tsimikas S, Philis-Tsimikas A, Alexopoulos S, Sigari F, Lee C, Reaven PD.
    Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):122-30. PubMed ID: 9888874
    [Abstract] [Full Text] [Related]

  • 31. [The effect of alimentary hypercholesterolemia on the level of lipids and essential fatty acids in rabbit enterohepatic circulation].
    Bogdarin IuA, Badeĭnova EN.
    Vopr Med Khim; 1990 Jan; 36(1):33-7. PubMed ID: 2111601
    [Abstract] [Full Text] [Related]

  • 32. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy.
    Islam KN, O'Byrne D, Devaraj S, Palmer B, Grundy SM, Jialal I.
    Atherosclerosis; 2000 May; 150(1):217-24. PubMed ID: 10781654
    [Abstract] [Full Text] [Related]

  • 33. Subgram daily supplementation with docosahexaenoic acid protects low-density lipoproteins from oxidation in healthy men.
    Calzada C, Colas R, Guillot N, Guichardant M, Laville M, Véricel E, Lagarde M.
    Atherosclerosis; 2010 Feb; 208(2):467-72. PubMed ID: 19717153
    [Abstract] [Full Text] [Related]

  • 34. Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis.
    Viigimaa M, Abina J, Zemtsovskaya G, Tikhaze A, Konovalova G, Kumskova E, Lankin V.
    Blood Press; 2010 Jun; 19(3):164-8. PubMed ID: 20429692
    [Abstract] [Full Text] [Related]

  • 35. Inhibition of LDL oxidation by antioxidants.
    Esterbauer H, Waeg G, Puhl H, Dieber-Rotheneder M, Tatzber F.
    EXS; 1992 Jun; 62():145-57. PubMed ID: 1450582
    [Abstract] [Full Text] [Related]

  • 36. Cholesteryl ester hydroperoxide lability is a key feature of the oxidative susceptibility of small, dense LDL.
    Chancharme L, Thérond P, Nigon F, Lepage S, Couturier M, Chapman MJ.
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):810-20. PubMed ID: 10073990
    [Abstract] [Full Text] [Related]

  • 37. How different constituents of human plasma and low density lipoprotein determine plasma oxidizability by copper.
    Spranger T, Finckh B, Fingerhut R, Kohlschütter A, Beisiegel U, Kontush A.
    Chem Phys Lipids; 1998 Jan; 91(1):39-52. PubMed ID: 9488998
    [Abstract] [Full Text] [Related]

  • 38. Effect of uric acid and chemical analogues on oxidation of human low density lipoprotein in vitro.
    Schlotte V, Sevanian A, Hochstein P, Weithmann KU.
    Free Radic Biol Med; 1998 Nov 01; 25(7):839-47. PubMed ID: 9823550
    [Abstract] [Full Text] [Related]

  • 39. Cu(2+)-induced lipid oxidation in plasma: questionable relation between cholesterol oxidation and LDL modification.
    Tallineau C, Pontcharraud R, Guettier A, Piriou A.
    Biochem Int; 1992 Sep 01; 27(6):983-90. PubMed ID: 1445380
    [Abstract] [Full Text] [Related]

  • 40. Copper-induced low density lipoprotein oxidation is not a risk discriminator for intermittent claudication.
    Ziedén B, Mölgaard J, Olsson AG.
    Vasa; 1996 Sep 01; 25(2):121-6. PubMed ID: 8659213
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.